BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31735042)

  • 1. Prognostic significance of perioperative chemotherapy on resectable colorectal mucinous adenocarcinoma liver metastasis.
    Li C; Su D; Peng J; Fang Y; Zhou W; Li S; Luo B; Wan D; Pan Z
    Ann Palliat Med; 2019 Nov; 8(5):690-697. PubMed ID: 31735042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases.
    Lupinacci RM; Mello ES; Coelho FF; Kruger JA; Perini MV; Pinheiro RS; Fonseca GM; Cecconello I; Herman P
    Surgery; 2014 Jun; 155(6):1062-8. PubMed ID: 24856126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
    Viganò L; Russolillo N; Ferrero A; De Rosa G; Ferreri E; Forchino F; Sperti E; Capussotti L
    Ann Surg; 2014 Nov; 260(5):878-84; discussion 884-5. PubMed ID: 25379857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver Metastasis.
    Liao SW; Zhan JQ; Liu CT; Yu HT; Wen MJ
    Am J Clin Oncol; 2024 Jan; 47(1):30-39. PubMed ID: 38148710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features of colorectal mucinous adenocarcinoma].
    Song W; He YL; Cai SR; Zhang CH; Chen CQ; Peng JJ; Zhan WH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):487-90. PubMed ID: 19742341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after curative resection for stage I colorectal mucinous adenocarcinoma.
    Huang L; Luo S; Lai S; Liu Z; Hu H; Chen M; Kang L
    BMC Gastroenterol; 2022 Apr; 22(1):192. PubMed ID: 35436867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological, molecular features and prognosis of colorectal cancer with mucinous component.
    Li J; Yang L; Bai F; Cai Y; Zhang J; Wu Z; Fu Y; Deng Y
    Future Oncol; 2021 Apr; 17(11):1351-1362. PubMed ID: 33331169
    [No Abstract]   [Full Text] [Related]  

  • 11. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
    Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
    Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inverse effect of mucinous component on survival in stage III colorectal cancer.
    Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
    J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
    Araujo RL; Gönen M; Herman P
    Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
    Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
    Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucinous histology is associated with poor prognosis in locally advanced colorectal adenocarcinoma treated with postoperative first-line adjuvant chemotherapy: A systematic review and meta-analysis.
    Zhang Y; Chen Y; Huang J; Wu X; Tang R; Huang Q; Xu Y; Peng X; Fu K; Xiao S
    Eur J Surg Oncol; 2022 Oct; 48(10):2075-2081. PubMed ID: 35768312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
    Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
    Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
    Araujo R; Gonen M; Allen P; Blumgart L; DeMatteo R; Fong Y; Kemeny N; Jarnagin W; D'Angelica M
    Ann Surg Oncol; 2013 Dec; 20(13):4312-21. PubMed ID: 23897009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.
    Ayez N; van der Stok EP; Grünhagen DJ; Rothbarth J; van Meerten E; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2015 Jul; 41(7):859-67. PubMed ID: 25979624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.